The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s polycystic ovarian syndrome treatment market report forecasts the polycystic ovarian syndrome treatment market size to grow to $5.66 Billion by 2027, with a CAGR (compound annual growth rate) of almost 6%.

Learn More On The Polycystic Ovarian Syndrome Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/polycystic-ovarian-syndrome-treatment-global-market-report

Polycystic Ovarian Syndrome Treatment Market Size Forecast
The global polycystic ovarian syndrome treatment market is expected to grow from $4.26 billion in 2022 to $4.49 billion in 2023 at a compound annual growth rate (CAGR) of 5.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global polycystic ovarian syndrome treatment market is expected to grow to $5.66 billion in 2027 at a CAGR of 5.9%.

North America held the largest polycystic ovarian syndrome treatment market share.

Key Polycystic Ovarian Syndrome Treatment Market Driver ­– Rise In Genetic And Hormonal Disorders Globally
PCOS is a prevalent hormonal disorder among premenopausal women worldwide, with reproductive, endocrine, and metabolic abnormalities. The PCOS prevalence ranges from 2.2% to 26% globally and is highly variable. In China, the figures range between 2% to 7.5% and 6.3% in Sri Lanka, 9.13% in south India and 22.5% in Maharashtra. The rise in genetic and hormonal disorders globally is expected to increase the growth of the polycystic ovarian syndrome treatment market.

Request for A Sample Of The Global Polycystic Ovarian Syndrome Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2827&type=smp

Key Polycystic Ovarian Syndrome Treatment Market Trend – Adopting Laparoscopic Ovarian Drilling
Laparoscopic ovarian drilling is a surgical treatment performed by doctors in critical conditions that can cause ovulation in women with polycystic ovary syndrome (PCOS). Ovarian drilling is often used by women with PCOS who often do not ovulate despite having attempted weight loss and the use of fertility drugs. According to a 2021 study published on Taylor and Francis online, an American open access journal, the efficacy of ovarian drilling was variable in different literature. Ovulation and pregnancy rates were found to be 30%-90% and 13%-80% respectively.

Polycystic Ovarian Syndrome Treatment Market Segment
1) By Drug Type: Oral Contraceptives, Ornithine Decarboxylase Inhibitors, Insulin-Sensitizing Agents, Anti-Depressants, Diuretics, Aromatase Inhibitors
2) By Surgery Type: Ovarian Wedge Resection, Laparoscopic Ovarian Drilling
3) By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Gynecology Centers, Feminist Health Centers

Polycystic Ovarian Syndrome Treatment Market Major Players and Strategies
Major players in the polycystic ovarian syndrome treatment market are Bristol-Myer Squibb Company, Bayer AG, Pfizer Inc., Merck KGaA, Sanofi, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries Limited, Abbott, Addex Therapeutics Ltd., BIOCAD, Allergan PLC., Johnson and Johnson, Ferring BV, and Ferring Pharmaceuticals Inc.

In December 2021, Organon& Co., an American pharmaceutical company working to improve women’s health, acquired Forendo Pharma for $954 million. Through this acquisition Organon plans to bring innovation in the area of women’s health and develop better treatments. Forendo Pharma is a Finland-based clinical stage pharmaceutical company pioneering in the areas of intracrinology and polycystic ovarian syndrome (PCOS).

The Polycystic Ovarian Syndrome Treatment Global Market Report 2023 covers regional data on polycystic ovarian syndrome treatment market size, polycystic ovarian syndrome treatment market trends and drivers, opportunities, strategies, and polycystic ovarian syndrome treatment market competitor analysis. The countries covered in the polycystic ovarian syndrome treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Polycystic ovarian syndrome is a disorder in which hormones are out of control for females and they have male hormones that are higher than normal, which causes them to skip menstrual periods and makes pregnancy more difficult for them.

View More Reports Related To The Polycystic Ovarian Syndrome Treatment Market –
Ovarian Cancer Drugs Global Market Report 2023
Genito-Urinary Drugs Global Market Report 2022
Urinary Stone Treatment Devices And Equipment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: